GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biolase Inc (FRA:BTH0) » Definitions » E10

Biolase (FRA:BTH0) E10 : €-2,276.89 (As of Mar. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Biolase E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Biolase's adjusted earnings per share data for the three months ended in Mar. 2024 was €-0.331. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-2,276.89 for the trailing ten years ended in Mar. 2024.

During the past 3 years, the average E10 Growth Rate was 3.10% per year. During the past 5 years, the average E10 Growth Rate was 3.40% per year. During the past 10 years, the average E10 Growth Rate was 3.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Biolase was 46.30% per year. The lowest was -19.60% per year. And the median was 2.80% per year.

As of today (2024-05-24), Biolase's current stock price is €0.1564. Biolase's E10 for the quarter that ended in Mar. 2024 was €-2,276.89. Biolase's Shiller PE Ratio of today is .


Biolase E10 Historical Data

The historical data trend for Biolase's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biolase E10 Chart

Biolase Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -8,594.31 -10,025.60 -10,786.20 -2,902.87 -2,715.14

Biolase Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2,793.97 -2,614.70 -2,664.00 -2,715.14 -2,276.89

Competitive Comparison of Biolase's E10

For the Medical Devices subindustry, Biolase's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biolase's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Biolase's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Biolase's Shiller PE Ratio falls into.



Biolase E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Biolase's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.331/131.7762*131.7762
=-0.331

Current CPI (Mar. 2024) = 131.7762.

Biolase Quarterly Data

per share eps CPI Adj_EPS
201406 -1,468.121 100.560 -1,923.870
201409 -728.429 100.428 -955.807
201412 -761.283 99.070 -1,012.610
201503 -975.772 99.621 -1,290.726
201506 -1,254.573 100.684 -1,641.999
201509 -940.923 100.392 -1,235.077
201512 -430.862 99.792 -568.955
201603 -737.581 100.470 -967.406
201606 -626.580 101.688 -811.976
201609 -940.923 101.861 -1,217.259
201612 -778.649 101.863 -1,007.311
201703 -701.250 102.862 -898.368
201706 -1,357.250 103.349 -1,730.574
201709 -629.250 104.136 -796.271
201712 -443.625 104.011 -562.048
201803 -506.875 105.290 -634.385
201806 -513.600 106.317 -636.590
201809 -492.775 106.507 -609.690
201812 -725.175 105.998 -901.535
201903 -508.875 107.251 -625.243
201906 -398.250 108.070 -485.612
201909 -567.500 108.329 -690.330
201912 -292.500 108.420 -355.511
202003 -429.875 108.902 -520.170
202006 -266.400 108.767 -322.755
202009 -445.725 109.815 -534.863
202012 -143.850 109.897 -172.489
202103 -115.920 111.754 -136.688
202106 -9.960 114.631 -11.450
202109 -45.900 115.734 -52.262
202112 -66.375 117.630 -74.358
202203 -73.548 121.301 -79.899
202206 -87.013 125.017 -91.718
202209 -111.464 125.227 -117.294
202212 -120.832 125.222 -127.157
202303 -16.653 127.348 -17.232
202306 -8.242 128.729 -8.437
202309 -3.645 129.860 -3.699
202312 -5.990 129.419 -6.099
202403 -0.331 131.776 -0.331

Add all the adjusted EPS together and divide 10 will get our e10.


Biolase  (FRA:BTH0) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Biolase E10 Related Terms

Thank you for viewing the detailed overview of Biolase's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Biolase (FRA:BTH0) Business Description

Traded in Other Exchanges
Address
27042 Towne Centre Drive, Suite 270, Lake Forest, CA, USA, 92610
Biolase Inc is a US-based medical device company. It develops, manufactures, markets, and sells laser systems in dentistry and medicine. The company also markets, sells and distributes dental imaging equipment, including cone beam digital x-rays and CAD/CAM intraoral scanners. It offers two categories of laser system products: Waterlase (all-tissue) systems and Diode (soft-tissue) systems which allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a broad range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The majority of the company's revenue comes from the United States.

Biolase (FRA:BTH0) Headlines

No Headlines